Published in Biochim Biophys Acta on December 21, 1982
Targeted drug delivery to tumors: myths, reality and possibility. J Control Release (2011) 2.69
Heterogeneous vascular dependence of tumor cell populations. Am J Pathol (2001) 1.31
Early origin and pervasiveness of cellular heterogeneity in some malignant transformations. Proc Natl Acad Sci U S A (1984) 1.19
Mitogenic hormones and tumor promoters greatly increase the incidence of colony-forming cells bearing amplified dihydrofolate reductase genes. Proc Natl Acad Sci U S A (1983) 1.00
Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Lab Invest (2008) 1.00
Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines. Br J Cancer (1987) 0.96
Phase II study of 4-ipomeanol, a naturally occurring alkylating furan, in patients with advanced hepatocellular carcinoma. Invest New Drugs (2001) 0.85
Progression to steroid autonomy in S115 mouse mammary tumor cells: role of DNA methylation. J Cell Biol (1984) 0.84
Characterization of radiation sensitivity of human squamous carcinoma A431 cells. Br J Cancer (1987) 0.81
Distribution of anionic surface sites on human melanocytes and human melanoma cells in culture. Arch Dermatol Res (1983) 0.78
Conference report from the 2015 OECI Oncology Days, Portugal, 22-24 June-tumour heterogeneity and next generation sequencing: morphology and technology. Ecancermedicalscience (2015) 0.75
Dermal fibroblasts tumor suppression of ras-transformed keratinocytes is associated with induction of squamous cell differentiation. Am J Pathol (1994) 0.75
Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res (1978) 2.86
N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res (1979) 2.05
Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci (2001) 1.98
Clinical studies with systemic administration of antimetabolites of pyrimidine nucleosides in viral infections. Ann N Y Acad Sci (1965) 1.93
Aortic stiffness and pulse wave reflection in young subjects with migraine: A case-control study. Neurology (2010) 1.86
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging (2007) 1.65
Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience (2001) 1.64
A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J Immunol Methods (1997) 1.64
Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med (1981) 1.56
Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons. Eur J Neurosci (1995) 1.51
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology (2008) 1.50
Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalalgia (2008) 1.49
Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Cancer Res (1978) 1.48
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. Eur J Neurol (2008) 1.48
Tumor heterogeneity and drug resistance. J Clin Oncol (1986) 1.47
Medical alternatives to alternative medicine. Cancer (1999) 1.45
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol (1998) 1.41
Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci U S A (1991) 1.40
Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience (1997) 1.31
Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol (1993) 1.30
Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. Br J Pharmacol (1994) 1.22
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience (2006) 1.21
Identification of the enzymatic pathways of nucleotide metabolism in human lymphocytes and leukemia cells. Cancer Res (1973) 1.20
The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine. Cancer Res (1972) 1.19
Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma. Int J Cancer (1973) 1.18
Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J Pharmacol Exp Ther (1990) 1.17
Psoriasis and occlusive vascular disease. Br J Dermatol (1978) 1.15
Treatment of advanced Wegener's granulomatosis with azathioprine and duazomycin A. N Engl J Med (1968) 1.15
Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease. Amino Acids (2006) 1.15
Clinical and pharmacological implications of cancer cell differentiation and heterogeneity. Biochem Pharmacol (1979) 1.15
Polar solvents: a novel class of antineoplastic agents. J Clin Oncol (1984) 1.15
Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med (1969) 1.14
Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement. Neuroscience (1987) 1.12
Beneficial effects of triacetyl azauridine in psoriasis and mycosis fungoides. Ann Intern Med (1966) 1.12
Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J Neurosci (2000) 1.11
Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease. N Engl J Med (1966) 1.11
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers. Cancer Chemother Pharmacol (1994) 1.08
Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst (1995) 1.08
Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia (1995) 1.07
Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. Br J Pharmacol (1997) 1.07
Selective suppression of humoral immunity by antineoplastic drugs. Annu Rev Pharmacol Toxicol (1976) 1.05
Unilateral dopamine denervation blocks corticostriatal LTP. J Neurophysiol (1999) 1.03
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S. Cancer Res (1997) 1.02
Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol (1995) 1.02
Intrinsic membrane properties of neostriatal neurons can account for their low level of spontaneous activity. Neuroscience (1987) 1.02
Human tumor cell heterogeneity and metastasis. J Clin Oncol (1983) 1.01
Permissive role of interneurons in corticostriatal synaptic plasticity. Brain Res Brain Res Rev (1999) 1.01
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. Neurobiol Dis (2009) 0.99
In vivo selection of a highly metastatic cell line from a human pancreatic carcinoma in the nude mouse. Cancer (1992) 0.99
Actions of TNF and IFN-gamma on angiogenesis in vitro. J Invest Dermatol (1990) 0.98
Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. J Med Chem (1990) 0.97
Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man. Biochem Pharmacol (1966) 0.97
[Mouse teratocarcinoma: isolation and characterization of two muscle cell lines (author's transl)]. Ann Microbiol (Paris) (1976) 0.97
Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor. Clin Cancer Res (1998) 0.96
Heterogeneity of potential for hematogenous metastasis in a human pancreatic carcinoma. J Surg Res (1990) 0.96
Motivations and rewards for volunteering to be an experimental subject. Clin Pharmacol Ther (1972) 0.95
Training program in medical oncology. Ann Intern Med (1973) 0.95
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience (2004) 0.95
Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J Natl Cancer Inst (1993) 0.95
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. Eur J Neurol (2008) 0.95
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. Cephalalgia (2008) 0.94
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse. Neuropharmacology (1997) 0.94
Retinal architecture predicts pupillary reflex metrics in MS. Mult Scler (2008) 0.94
Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res (1990) 0.94
Adaptation of Sinclair swine melanoma cells to long-term growth in vitro. Cancer Res (1979) 0.94
Nucleotide profiles of the formed elements of human blood determined by high-pressure liquid chromatography. Blood (1973) 0.93
Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors. Cancer Res (1985) 0.93
N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells. Cancer Res (1977) 0.93
NF-kappaB activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia (2006) 0.93
Effects of anoxia on rat midbrain dopamine neurons. J Neurophysiol (1994) 0.92
Responses of rat substantia nigra compacta neurones to L-DOPA. Br J Pharmacol (1990) 0.92
The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Life Sci (1992) 0.91
Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res (1988) 0.91
The "induction" of leukocyte and erythrocyte dihydrofolate reductase by methotrexate. II. Clinical and pharmacologic studies. Clin Pharmacol Ther (1966) 0.90
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase. Neurobiol Dis (2006) 0.90
Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. Neuropharmacology (2005) 0.90
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. Neuropharmacology (2003) 0.90
Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Mol Cell Neurosci (2001) 0.90
Chemotherapy of cell-line-derived human colon carcinomas in mice immunosuppressed with antithymocyte serum. Cancer (1977) 0.89
Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages. Acta Neurochir Suppl (1994) 0.89
Neurotensin induces an inward current in rat mesencephalic dopaminergic neurons. Neurosci Lett (1993) 0.89
Differential characteristics of two newly established human breast carcinoma cell lines. Cancer Res (1985) 0.89
Synergism of methotrexate with imuran and with 5-fluorouracil and their effects on hemolysin plaque-forming cell production in the mouse. Cancer Res (1974) 0.89
The mechanism of amphetamine-induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro. Br J Pharmacol (1989) 0.89
Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells. Histochem J (1984) 0.89
Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice. Cancer Res (1982) 0.89
Structure-activity relationship of quinoline carboxylic acids. A new class of inhibitors of dihydroorotate dehydrogenase. Biochem Pharmacol (1990) 0.89
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. Neuroscience (2005) 0.88
Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology (2001) 0.88
Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation: an in vitro study. Neuroscience (1984) 0.88
Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. Cephalalgia (2006) 0.88
Characterization of a defect in the pathway for converting 5'-deoxy-5'-methylthioadenosine to methionine in a subline of a cultured heterogeneous human colon carcinoma. J Biol Chem (1984) 0.88
Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine. Cancer Res (1984) 0.88